Glenn P Muir is of REPLIGEN CORP. Currently has a direct ownership of 32,283 shares of RGEN, which is worth approximately $4.6 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 19,000 shares (Common Stock) at a price of $36.29 per share, resulting in proceeds of $689,510. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.3K
143.04% 3M change
325.78% 12M change
Total Value Held $4.6 Million

GLENN P MUIR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2024
BUY
Exercise of conversion of derivative security
$689,510 $36.29 p/Share
19,000 Added 37.05%
32,283 Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
$181,450 $36.29 p/Share
5,000 Added 27.35%
13,283 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
-
701 Added 7.8%
8,283 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
686 Added 8.3%
7,582 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
534 Added 7.19%
6,896 Common Stock
May 13 2021
BUY
Grant, award, or other acquisition
-
457 Added 6.7%
6,362 Common Stock

Also insider at

GTHX
G1 Therapeutics, Inc. Healthcare
STIM
Neuronetics, Inc. Healthcare
GPM

Glenn P Muir

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN